1. Home
  2. TROX vs ALVO Comparison

TROX vs ALVO Comparison

Compare TROX & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tronox Holdings plc (UK)

TROX

Tronox Holdings plc (UK)

HOLD

Current Price

$5.87

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

Logo Alvotech

ALVO

Alvotech

HOLD

Current Price

$3.45

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TROX
ALVO
Founded
2018
2013
Country
United States
Luxembourg
Employees
N/A
1460
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.3B
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
TROX
ALVO
Price
$5.87
$3.45
Analyst Decision
Hold
Buy
Analyst Count
8
4
Target Price
$6.36
$8.00
AVG Volume (30 Days)
2.5M
945.8K
Earning Date
05-06-2026
05-06-2026
Dividend Yield
2.07%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,898,000,000.00
N/A
Revenue This Year
$6.94
$13.28
Revenue Next Year
$5.91
$18.63
P/E Ratio
N/A
$18.20
Revenue Growth
N/A
N/A
52 Week Low
$2.86
$2.94
52 Week High
$10.59
$9.94

Technical Indicators

Market Signals
Indicator
TROX
ALVO
Relative Strength Index (RSI) 32.98 46.79
Support Level $5.39 $3.19
Resistance Level $8.61 $3.94
Average True Range (ATR) 0.37 0.18
MACD 0.02 -0.02
Stochastic Oscillator 21.86 34.21

Price Performance

Historical Comparison
TROX
ALVO

About TROX Tronox Holdings plc (UK)

Tronox Holdings PLC is a vertically integrated manufacturer of TiO2 pigment. It operates titanium-bearing mineral sand mines and beneficiation and smelting operations in Australia & South Africa to produce feedstock materials that can be processed into TiO2 for pigment, high-purity titanium chemicals, including titanium tetrachloride, and ultrafine TiO2 used in certain specialty applications. TiO2 and titanium feedstock, are used to produce paints and coatings, as well as plastics, paper, and printing ink. It has three pigment production facilities in the United States, the Netherlands, and Western Australia and three mining operations in Western Australia and South Africa. Europe, the Middle East, and Africa regions contribute the majority of revenue.

About ALVO Alvotech

Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.

Share on Social Networks: